Total Reports
510
FDA CVM filings
Horse /
FDA CVM · 2025 release 510 reports on file
Warmblood (unspecified) - FDA Adverse Event Profile
Adverse-event records for Warmblood (unspecified) (Horse) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Warmblood (unspecified) ranks #138 by report volume among horse breeds - 36 of 510 reports (7.1%) recorded a death outcome.
- #138
- most-reported horse breed
- 7.1%
- death-coded report share
- 95
- Lack of efficacy - NOS - top reaction
- 12.8 yr
- average age at report
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Deaths Reported
36
of 510 reports
Death Rate
7.1%
death-coded share
Avg Age at Report
12.8 yr
471.6 kg avg weight
Death-Coded Outcome Share
Warmblood (unspecified) death-coded reports 7.1%
Cross-breed median
7.1% of 510 warmblood (unspecified) reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 471.6 kg (1039.9 lbs)
Top Reported Reactions
Lack of efficacy - NOS 95
INEFFECTIVE, GASTRIC ULCER(S) 77
Injection site swelling 48
Colic 41
Fever 30
Injection site pain 27
Lethargy (see also Central nervous system depression in 'Neurological') 26
Partial lack of efficacy 24
Most Referenced Drugs
Omeprazole 159
Ceftiofur Crystalline Free Acid 66
Pergolide Mesylate 51
Detomidine Hydrochloride 39
Polysulfated Glycosaminoglycan 36
Sucralfate 36
Hyaluronate Sodium 19
Misoprostol 17
Outcome Breakdown
Recovered/Normal
201 (39.3%)
Outcome Unknown
155 (30.3%)
Ongoing
107 (20.9%)
Euthanized
25 (4.9%)
Recovered with Sequela
12 (2.3%)
Died
11 (2.2%)
Gender Distribution
Male 331 (64.9%)
Female 150 (29.4%)
Unknown 22 (4.3%)
Mixed 7 (1.4%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 1 | |
| 2011 | 3 | |
| 2012 | 15 | |
| 2013 | 24 | |
| 2014 | 20 | |
| 2015 | 34 | |
| 2016 | 22 | |
| 2017 | 31 | |
| 2018 | 44 | |
| 2019 | 37 | |
| 2020 | 42 | |
| 2021 | 36 | |
| 2022 | 45 | |
| 2023 | 55 | |
| 2024 | 72 | |
| 2025 | 29 | |
Warmblood (unspecified) Pet Health Insights
Warmblood (unspecified) accounts for 510 FDA adverse event reports, ranking #138 by volume among horse breeds, with 36 reports (7.1%) coded as a death outcome. Mean age at report: 12.8 years, average weight 471.6 kg (1039.9 lbs).
Top reported signs: Lack of efficacy - NOS (95), INEFFECTIVE, GASTRIC ULCER(S) (77), Injection site swelling (48). Most-referenced drug: Omeprazole (159 reports), followed by Ceftiofur Crystalline Free Acid (66) and Pergolide Mesylate (51).
Outcome coding on 511 status-recorded reports is dominated by Recovered/Normal (39.3%). Annual submissions ranged 2,010-2,025 across 16 years on file.
Horse Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Warmblood (unspecified)? ▼
There are 510 adverse event reports involving Warmblood (unspecified) in the FDA database, with 36 reports involving death (7.1% death rate). Warmblood (unspecified) ranks #138 by report volume.
What are the most common adverse reactions reported for Warmblood (unspecified)? ▼
The most commonly reported adverse reactions for Warmblood (unspecified) are Lack of efficacy - NOS (95 reports), INEFFECTIVE, GASTRIC ULCER(S) (77 reports), Injection site swelling (48 reports), Colic (41 reports), Fever (30 reports).
What drugs are most frequently associated with Warmblood (unspecified) adverse events? ▼
The drugs most frequently referenced in Warmblood (unspecified) adverse event reports are Omeprazole (159 reports), Ceftiofur Crystalline Free Acid (66 reports), Pergolide Mesylate (51 reports), Detomidine Hydrochloride (39 reports), Polysulfated Glycosaminoglycan (36 reports).
What is the average age of Warmblood (unspecified) in adverse event reports? ▼
The average age of Warmblood (unspecified) at the time of adverse event reports is 12.8 years, with an average weight of 471.6 kg (1039.9 lbs).
Does a high number of adverse event reports mean Warmblood (unspecified) is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Warmblood (unspecified) safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.